Inke S.A: APIs manufacturing plant.
01 1Inke S.A
02 1LGM Pharma
03 1Seqens
04 1Beijing Breathgreen Healthcare
05 1Cipla
06 1GSK
07 1Guangdong Raffles PharmaTech Co Ltd
08 1Guangzhou Topwork Chemical
09 1Harman Finochem
10 1Hikma Pharmaceuticals
11 1Hovione
12 1Jayco Chemical Industries
13 1Lupin Ltd
14 1Melody Healthcare Pvt Ltd
15 1Olon S.p.A
16 1R L Fine Chem
17 1Shenzhen HwaGen Pharmaceutical
18 1Sterling Chemical Malta
19 1Sterling Spa
20 1Teva API
21 1Teva Pharmaceutical Industries
01 4China
02 1France
03 6India
04 2Israel
05 2Italy
06 1Malta
07 1Portugal
08 1Spain
09 1U.S.A
10 2United Kingdom
01 9Active
02 12Blank
01 21Blank
01 21Blank
01 21Blank
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-07-12
Pay. Date : 2023-01-09
DMF Number : 36482
Submission : 2023-06-16
Status : Active
Type : II
NDC Package Code : 64567-0030
Start Marketing Date : 2022-01-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CN |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0626
Start Marketing Date : 2019-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38379
Submission : 2023-05-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38295
Submission : 2023-04-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35420
Submission : 2021-04-25
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-05-30
Pay. Date : 2023-01-13
DMF Number : 37680
Submission : 2023-03-08
Status : Active
Type : II
NDC Package Code : 17337-0434
Start Marketing Date : 2024-06-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-11-12
Pay. Date : 2020-09-08
DMF Number : 32945
Submission : 2018-08-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39843
Submission : 2024-04-15
Status : Active
Type : II
NDC Package Code : 59057-011
Start Marketing Date : 2022-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26339
Submission : 2012-11-29
Status : Active
Type : II
NDC Package Code : 52482-012
Start Marketing Date : 2014-08-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : GlaxoSmithKline Inc.
Registration Date : 2014-07-01
Registration Number : Number 2480-13-ND
Manufacturer Name : Glaxo Wellcome Manufacturing Pte Ltd@[micronization process manufacturing company] Glaxo Operations UK Ltd
Manufacturer Address : 1 Pioneer Sector 1, Singapore 628413@Priory Street, Ware, Hertfordshire, SG12 0DJ, United Kingdom
We have 21 companies offering Umeclidinium Bromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?